Wednesday, September 24, 2014 12:39:49 PM
Recent PTCT News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 11:55:18 AM
- Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients • PR Newswire (US) • 06/20/2024 10:30:00 AM
- PTC Therapeutics to Participate at Upcoming Investor Conference • PR Newswire (US) • 05/29/2024 12:00:00 PM
- PTC Therapeutics Announces Validation of Sepiapterin European MAA • PR Newswire (US) • 05/28/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 09:20:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2024 02:12:33 PM
- PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation • PR Newswire (US) • 05/20/2024 04:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 11:20:54 AM
- PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation • PR Newswire (US) • 05/20/2024 11:00:00 AM
- PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™ • PR Newswire (US) • 05/14/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 09:20:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2024 09:20:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2024 07:30:30 PM
- PTC Therapeutics to Participate at Upcoming Investor Conferences • PR Newswire (US) • 05/02/2024 12:00:00 PM
- PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results • PR Newswire (US) • 04/25/2024 08:05:00 PM
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/23/2024 08:30:00 PM
- PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results • PR Newswire (US) • 04/11/2024 12:00:00 PM
- PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA • PR Newswire (US) • 03/28/2024 12:30:00 PM
- PTC Therapeutics Provides Key Regulatory Updates • PR Newswire (US) • 03/19/2024 11:30:00 AM
- PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 02/29/2024 09:05:00 PM
- PTC Therapeutics to Participate at Upcoming Investor Conferences • PR Newswire (US) • 02/27/2024 10:20:00 PM
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 02/22/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:00:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:00:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:00:26 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM